Skip to content
OpenCapital
Get started

Collegium Pharmaceutical, Inc. COLL Other Financing

Other Financing at other companies

Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc. INDV
$3M—
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$0-100%
Viatris logo
ViatrisVTRS
-$300K+99.7%

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.13B+17.9%
Enterprise value$845.67M-0.3%
P/E15.1×-6.8×
P/S1.4×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0×0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s other financing?
Collegium Pharmaceutical, Inc. (COLL) reported other financing of $0 in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s other financing changed year-over-year?
Collegium Pharmaceutical, Inc.'s other financing decreased by 100.0% year-over-year, from $555K to $0.
What does other financing mean?
Miscellaneous financing cash flows not classified in specific line items.